|
Luminescent Measurements
|
E05.196.712.516 |
|
|
Lysinoalanine
|
D12.125.042.475 |
|
|
Amniocentesis
|
E04.665.600.309 |
|
|
Guillain-Barre Syndrome
|
C10.314.750.450 |
|
|
Golgi-Mazzoni Corpuscles
|
A08.800.950.750.300 |
|
|
Bland White Garland Syndrome
|
C14.280.400.210.249 |
|
|
Disability Studies
|
I02.158.405.500 |
|
|
Interdisciplinary Studies
|
I02.158.405 |
|
|
Valsartan
|
D12.125.070.950.550 |
|
|
Thapsigargin
|
D02.455.426.392.368.284.500.888 |
|
|
Sesquiterpenes, Guaiane
|
D02.455.426.392.368.284.500 |
|
|
Laminopathies
|
D000083083 |
[Congenital neuromuscular and muscular dystrophy diseases associated with mutations in the LAMIN TYPE A (Lamin A/C or LMNA gene). It includes CARDIOMYOPATHY, DILATED, 1A; CHARCOT-MARIE-TOOTH DISEASE, type 2B1; EMERY-DREIFUSS MUSCULAR DYSTROPHY, types 2 and 3; HUTCHINSON-GILFORD PROGERIA SYNDROME; LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; Malouf syndrome; Mandibuloacral dysplasia; LMNA-related muscular dystrophy; Restrictive dermopathy, lethal; Heart-hand syndrome, Slovenian type.
] |
|
Water Resources
|
J01.728.500 |
|
|
Natural Resources
|
J01.728 |
|
|
Collagen Type XII
|
D12.776.860.300.250.400.550.300 |
|
|
Trigeminal Neuralgia
|
C10.292.319.625.700.700 |
|
|
Popliteal Artery Entrapment Syndrome
|
D000083082 |
[Entrapment of the POPLITEAL ARTERY in the LEG due to an abnormal course of the artery often associated with onset of development and/or overuse of the gastrocnemius or popliteus muscles on the back of the leg. It is most often associated with runners and other athletes with enlarged calf muscle that compresses the popliteal artery.
] |
|
NG-Nitroarginine Methyl Ester
|
D12.125.068.050.525 |
|
|
Enterovirus, Bovine
|
B04.820.578.750.284.200 |
|
|
Superoxides
|
D01.650.550.750.800 |
|
